Prior common cold could protect against Omicron + Pfizer and Moderna race to produce omicron jabs
The Health Ministry reported 951 new covid-19 infections yesterday, up from 912 the day before. Egypt has now disclosed a total of 393,808 confirmed cases of covid-19. The ministry also reported 31 new deaths, bringing the country’s total death toll to 21,995.
Had a cold lately? It may offer some protection against covid-19: A small UK study found high levels of T cells — protective immune cells created by the body to fight some colds — in those who didn’t contract covid-19 despite being in close contact with an infected person, Bloomberg reported. T cells tend to survive longer in the human body than antibodies from covid vaccines and protect against a wider range of pathogens, potentially making them effective against different variants.
Pfizer’s omicron-specific booster will be ready in March, while Moderna’s will land in the fall, the CEOs of the two drugmakers told CNBC in separate interviews. Pfizer is already manufacturing its jab and expects trial results within days. Moderna’s booster is scheduled to enter clinical trials soon.
The US continues to break records: A record 132.6k people in the US are currently in hospital due to covid-19 as omicron sweeps the country, according to a Reuters tally.